Femme et Homme
- | Pays :
- United States
- Bulgaria
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this two-part study is to investigate the safety, tolerability and efficacy of LY3016859 after multiple intravenous (IV) dosing's in participants with diabetic nephropathy (DN). Part A will be dose escalation for safety and tolerability and Part B will evaluate Proteinuria.
Critère d'inclusion
- Diabetic nephropathy